| 000 | 01459 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516130709.0 | ||
| 264 | 0 | _c20130819 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.4161/cbt.23374 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWettersten, Hiromi I | |
| 245 | 0 | 0 |
_aA novel p21 attenuator which is structurally related to sorafenib. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cMar 2013 |
||
| 300 |
_a278-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xchemistry |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 650 | 0 | 4 |
_araf Kinases _xantagonists & inhibitors |
| 700 | 1 | _aHee Hwang, Sung | |
| 700 | 1 | _aLi, Cuiwen | |
| 700 | 1 | _aShiu, Eunice Y | |
| 700 | 1 | _aWecksler, Aaron T | |
| 700 | 1 | _aHammock, Bruce D | |
| 700 | 1 | _aWeiss, Robert H | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 14 _gno. 3 _gp. 278-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.23374 _zAvailable from publisher's website |
| 999 |
_c22402099 _d22402099 |
||